SuperworthScinai Immunotherapeutics market cap SCNI
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $783.1M
- Highest close in our data
- $20.5B
- Jul 2020
Scinai Immunotherapeutics is worth $783.1M at the close on Oct 23, 2026, at $0.56 a share.
That is down 84% over the last year and down 18% over five years.
Its highest close in our data was $20.5B in Jul 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $783.1M | $783.1M | $10.2B | −67% |
| 2025 | $2.4B | $364M | $9.9B | +287% |
| 2024 | $620.3M | $516.3M | $835.7M | −21% |
| 2023 | $781.6M | $100.9M | $2.6B | +361% |
| 2022 | $169.7M | $169.7M | $963.1M | −84% |
| 2021 | $1.1B | $705.8M | $2.6B | −15% |
| 2020 | $1.3B | $1.2B | $20.5B | n/a |
Against its peers
Companies in Biotechnology nearest Scinai Immunotherapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| SCNIScinai Immunotherapeutics | $783.1M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| PLXProtalix BioTherapeutics | $205.5M |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Scinai Immunotherapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.